HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Luminol

5-Amino-2,3-dihydro-1,4-phthalazinedione. Substance that emits light on oxidation. It is used in chemical determinations.
Also Known As:
1,4-Phthalazinedione, 5-amino-2,3-dihydro-
Networked: 361 relevant articles (6 outcomes, 33 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Yüksel, Meral: 8 articles (01/2021 - 09/2005)
2. Panasenko, O M: 4 articles (04/2021 - 07/2013)
3. Yuksel, M: 4 articles (10/2017 - 03/2007)
4. Farkhutdinov, U R: 4 articles (08/2007 - 01/2000)
5. Mikhalchik, E V: 3 articles (04/2021 - 07/2016)
6. Akakın, Dilek: 3 articles (01/2021 - 01/2017)
7. Cappella, Annalisa: 3 articles (07/2018 - 01/2017)
8. Cattaneo, Cristina: 3 articles (07/2018 - 01/2017)
9. Sguazza, Emanuela: 3 articles (07/2018 - 01/2017)
10. Kuang, Xianghong: 3 articles (02/2012 - 02/2009)

Related Diseases

1. Neoplasms (Cancer)
2. Inflammation (Inflammations)
3. Infections
4. Sarcoidosis (Schaumann Disease)
5. Fibrosis (Cirrhosis)
12/01/2000 - "Histological examination of the kidney revealed a significant reduction in glomerular sclerosis, tubular injury, luminol protein cast accumulation, and interstitial fibrosis as well as urinary protein. "
08/01/1994 - "The reduction of Cypridina luciferin analog-dependent chemiluminescence in chronic active hepatitis and cirrhosis was more sensitive than Cypridina luciferin analog-dependent chemiluminescence; however, in hepatocellular carcinoma, luminol-dependent chemiluminescence was more reduced than luminol-dependent chemiluminescence. "
08/01/1994 - "Both Cypridina luciferin analog-dependent chemiluminescence and luminol-dependent chemiluminescence were significantly decreased in neutrophils from patients with chronic liver disease (hepatocellular carcinoma < cirrhosis < chronic active hepatitis) when they were compared with normal healthy subjects. "
07/18/2008 - "Pirfenidone (PFD) is focused on a new anti-fibrotic drug, which can minimize lung fibrosis etc. We evaluated the superoxide (O2*-) scavenging activities of PFD and the PFD-iron complex by electron spin resonance (ESR) spectroscopy, luminol-dependent chemiluminescence assay, and cytochrome c reduction assay. "
08/01/1994 - "To evaluate whether neutrophil bactericidal function, the ability to produce oxygen-derived free radicals, is altered in patients with chronic liver disease, we measured chemiluminescence amplified by a luciferin analog (Cypridina luciferin analog-dependent chemiluminescence) and luminol (luminol-dependent chemiluminescence) in response to N-formyl-Met-Lue-Phe by neutrophils from patients with chronic liver diseases due to C and/or B type hepatitis: chronic active hepatitis, cirrhosis and hepatocellular carcinoma. "

Related Drugs and Biologics

1. Proteins (Proteins, Gene)
2. Hyaluronic Acid (Hyaluronan)
3. 1-phenyl-3,3-dimethyltriazene (PDT)
4. Nanoconjugates
5. Indicators and Reagents (Reagents)
6. Metal-Organic Frameworks
7. manganese ferrite
8. Zymosan
9. Reactive Oxygen Species (Oxygen Radicals)
10. Oxygen (Dioxygen)

Related Therapies and Procedures

1. Therapeutics
2. Aftercare (After-Treatment)
3. Continuous Ambulatory Peritoneal Dialysis (CAPD)
4. Lasers (Laser)
5. Intraperitoneal Injections